Alzheimer’s Disease (AD) is the most common progressive form of dementia. It is typically late onset (95% age >60 years), characterized by neuroimaging findings of cerebral cortical atrophy with cerebral amyloid angiopathy and CSF fluid measurements of amyloid-beta peptide, total or phosphorylated tau (Cohen AD 2018). Neuropathological findings that are diagnostic include neuritic plaques containing beta-amyloid, neurofibrillary tangles consisting of hyper-phosphorylated microtubule-associated protein tau, and amyloid angiopathy, described by accumulations of amyloid-beta proteins in the vascular smooth muscle of small cerebral arteries and capillaries.
Cohen, AD et al. (2019) Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease. Mol Cell Neurosci. 97:3-17. https://doi.org/10.1016/j.mcn.2018.12.004
Crews, L; Masliah E. (2010) Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet. 19(R1):R12-R20. https://doi.org/10.1093/hmg/ddq160
Dal Pra, I et al. (2019) Family C G-Protein-Coupled Receptors in Alzheimer's Disease and Therapeutic Implications. Front. Pharmacol. https://doi.org/10.3389/fphar.2019.01282
Khoury, R; Ghossoub, E. (2019) Diagnostic biomarkers of Alzheimer's disease: a state-of-the-art review. Biomarkers in Neuropsychiatry. 1:100005. https://doi.org/10.1016/j.bionps.2019.100005
Liu, S et al. (2018) A Decade of Blood Biomarkers for Alzheimer's Disease Research. J Alzheimer's Disease. 62(3):1181-1198.
Rychlik, M et al. (2020) Zinc-mediated Neurotransmission in Alzheimer's Disease: A potential role of the GPR39 in Dementia. Curr Neuropharmacol. 18(1):2-13. https://doi.org/10.2174/1570159X17666190704153807
Thathiah, A et al. (2011) The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nature Reviews Neuroscience. 12:73-87. https://doi.org/10.1038/nrn2977
Tiwari, S et al. (2019) Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 14:5541-5554. https://doi.org/10.2147/IJN.S200490
Xu, Y et al. (2020) GPR68 deletion impairs hippocampal long-term potentiation and passive avoidance behavior. Molecular Brain. 13:132. https://doi.org/10.1186/s13041-020-00672-8
Yiannopoulou, KG; Papageorgiou SG. (2020) Current and Future Treatments in Alzheimer Disease: An Update. J Cent Nerv Syst Dis. 12:1179573520907397. https://doi.org/10.1177/1179573520907397
Zhao, J et al. (2016) G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs. Frontiers in Aging Neuroscience. 8:58. https://doi.org/10.3389/fnagi.2016.00058
